FYERS
Home
/
Stocks
/
Results
/
Entero Healthcare Solutions Results

Entero Healthcare Solutions Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-30%26%29%
---36%
---67%
3%4%7%9%

Peer Comparison

Symbol
ADANIENT
AEGISLOG
CPPLUS
PREMIERENE
REDINGTON
HONASA
LLOYDSENT
SGMART
MMTC
EBGNG
ENTERO
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
2,900₹404763 Cr54.37-8.91105.06₹9339 Cr
1,369.7₹49337 Cr39.4313.841.65₹898 Cr
3,800.1₹45264 Cr94.8412.0745.29₹368 Cr
898₹41326 Cr24.8210.245.28₹1510 Cr
406.4₹31353 Cr18.436.2224.36₹1490 Cr
472.95₹15804 Cr63.52.778.99₹200 Cr
75.58₹11326 Cr100.860.380.91₹283 Cr
717.15₹9230 Cr74.243.6210.96₹111 Cr
57.97₹9063 Cr20.260.693.01₹387 Cr
676.65₹8154 Cr57.252.5413.51₹132 Cr
1,852.2₹8023 Cr63.988.7739.55₹115 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Long-Term Borrowings
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
——————
₹44 Cr₹44 Cr₹43 Cr₹668 Cr₹623 Cr₹517 Cr
₹6 Cr₹4 Cr₹2 Cr₹0₹0₹0
₹1639 Cr₹1676 Cr₹1593 Cr-₹73 Cr-₹62 Cr-₹32 Cr
₹1639 Cr₹1676 Cr₹1593 Cr-₹73 Cr-₹62 Cr-₹32 Cr
₹1689 Cr₹1724 Cr₹1638 Cr₹595 Cr₹561 Cr₹485 Cr
₹64 Cr₹46 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr
₹0₹0₹0₹0₹37 Cr₹0
₹100 Cr₹0₹46 Cr₹31 Cr₹37 Cr₹0
₹23 Cr₹0₹0₹0₹0₹0
-₹54 Cr-₹14 Cr-₹19 Cr-₹1 Cr₹1 Cr₹1 Cr
₹116 Cr₹78 Cr₹49 Cr₹50 Cr₹58 Cr₹53 Cr
₹22 Cr₹10 Cr₹7 Cr₹5 Cr₹4 Cr₹3 Cr
₹206 Cr₹73 Cr₹83 Cr₹85 Cr₹100 Cr₹57 Cr
——————
₹725 Cr₹397 Cr₹230 Cr₹211 Cr₹140 Cr₹97 Cr
₹397 Cr₹138 Cr₹135 Cr₹67 Cr₹65 Cr₹30 Cr
₹444 Cr₹299 Cr₹230 Cr₹342 Cr₹248 Cr₹142 Cr
₹21 Cr₹11 Cr₹7 Cr₹4 Cr₹9 Cr₹20 Cr
₹1588 Cr₹845 Cr₹602 Cr₹624 Cr₹462 Cr₹289 Cr
₹3546 Cr₹2688 Cr₹2326 Cr₹1307 Cr₹1125 Cr₹833 Cr
₹6 Cr₹4 Cr₹35 L₹30 L₹1 L₹31 L
₹567 Cr₹299 Cr₹276 Cr₹374 Cr₹285 Cr₹142 Cr
——————
₹1129 Cr₹686 Cr₹383 Cr₹339 Cr₹311 Cr₹218 Cr
₹171 Cr₹127 Cr₹94 Cr₹71 Cr₹49 Cr₹30 Cr
₹958 Cr₹559 Cr₹289 Cr₹268 Cr₹262 Cr₹189 Cr
₹0₹0₹0₹0₹59 L₹0
₹72 Cr₹47 Cr₹20 Cr₹14 Cr₹12 Cr₹10 Cr
₹5 Cr₹6 Cr₹5 Cr₹1 Cr₹0₹0
₹1038 Cr₹613 Cr₹315 Cr₹284 Cr₹274 Cr₹201 Cr
——————
₹130 Cr₹58 Cr₹0₹0₹0₹0
₹842 Cr₹660 Cr₹421 Cr₹342 Cr₹310 Cr₹244 Cr
₹1212 Cr₹830 Cr₹615 Cr₹515 Cr₹375 Cr₹242 Cr
₹162 Cr₹260 Cr₹893 Cr₹107 Cr₹105 Cr₹83 Cr
₹89 Cr₹66 Cr₹41 Cr₹23 Cr₹24 Cr₹32 Cr
₹68 Cr₹201 Cr₹41 Cr₹37 Cr₹36 Cr₹32 Cr
₹2503 Cr₹2076 Cr₹2011 Cr₹1023 Cr₹851 Cr₹633 Cr
₹916 Cr₹1231 Cr₹1409 Cr₹399 Cr₹389 Cr₹344 Cr
₹3546 Cr₹2688 Cr₹2326 Cr₹1307 Cr₹1125 Cr₹833 Cr
₹387₹395₹376-₹167-₹151-₹3,175
₹387₹395₹376-₹167-₹151-₹3,175

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
₹179 Cr₹139 Cr₹36 Cr-₹4 Cr-₹20 Cr-₹11 Cr
₹107 Cr₹44 Cr₹87 Cr₹71 Cr₹42 Cr₹43 Cr
-₹136 Cr-₹222 Cr-₹146 Cr-₹100 Cr-₹46 Cr-₹96 Cr
₹150 Cr-₹39 Cr-₹24 Cr-₹33 Cr-₹24 Cr-₹64 Cr
₹96 Cr-₹77 Cr-₹37 Cr-₹45 Cr-₹35 Cr-₹69 Cr
-₹303 Cr₹220 Cr-₹705 Cr-₹49 Cr-₹162 Cr-₹31 Cr
₹124 Cr-₹74 Cr₹863 Cr₹73 Cr₹211 Cr₹89 Cr
-₹83 Cr₹69 Cr₹121 Cr-₹21 Cr₹14 Cr-₹11 Cr
₹229 Cr₹148 Cr₹25 Cr₹47 Cr₹32 Cr₹43 Cr
₹80 L₹12 Cr₹1 Cr₹0₹0₹0
₹147 Cr₹229 Cr₹148 Cr₹25 Cr₹47 Cr₹32 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)1,835.00
Volume (₹)2.48 L
High (₹)1,875.00
Upper Circuit2,211.00
Low (₹)1,780.00
Lower Circuit1,474.00
Prev Close1,842.50
52W High (₹)1,920.00
Price1,852.20
52W Low (₹)944.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)8022.83 Cr
Div. Yield (%)0.00
PE Ratio63.98
Debt to Equity0.34
Price to Book3.22
Book Value386.61
EPS (TTM)28.81
Face Value10.00
ROE (%)8.57

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
ADANIENTNSE
AEGISLOGNSE
CPPLUSNSE
PREMIERENENSE
REDINGTONNSE
HONASANSE
LLOYDSENTNSE
SGMARTNSE
MMTCNSE
EBGNGNSE
ENTERONSE
LTP
1W Low
1W High
Market cap (₹)
2900-120 (-3.97%)
2898.20
3026.10
4,04,763Cr
1369.7-45.7 (-3.23%)
1348.40
1528.70
49,337Cr
3800.1+445 (13.26%)
3338.80
3874.60
45,264Cr
898-4 (-0.44%)
885
920
41,326Cr
406.4+6.55 (1.64%)
390.70
419.50
31,353Cr
472.95-6.6 (-1.38%)
465.55
492
15,804Cr
75.58+6.74 (9.79%)
67.23
77.15
11,326Cr
717.15-16.4 (-2.24%)
710.05
747.85
9,230Cr
57.97-2.3 (-3.82%)
57.45
60.99
9,063Cr
676.65-26.4 (-3.76%)
671.90
730
8,154Cr
1852.2+119.9 (6.92%)
1740.90
1875
8,023Cr

Entero Healthcare Solutions Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹100Cr; with other income of ₹3.01Cr, profit before interest and tax came to ₹87.69Cr. Interest expense was ₹20.57Cr; PBT before exceptional items stood at ₹67.12Cr. Cost mix (full year): raw materials ₹5914.84Cr; employee cost ₹245.5Cr; depreciation ₹12.3Cr; other expenses ₹1843.51Cr. Basis: consolidated annual results.

Entero Healthcare Solutions Ltd Quaterly Results Key Takeaways

Entero Healthcare Solutions Ltd reported ₹1940.49Cr total income from operations in Jun 2026, softer than ₹1909.93Cr in Mar 2026 but higher than ₹1403.82Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹100Cr; with other income of ₹3.01Cr, profit before interest and tax came to ₹87.69Cr. Interest expense was ₹20.57Cr, taking profit before tax to ₹67.12Cr. After tax of ₹15.07Cr, profit after tax stood at ₹52.05Cr (vs ₹45.13Cr in Mar 2026 and ₹30.23Cr in Jun 2025).